1. 2018
  2. The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation

    Chernaya, G., Mikhno, N., Khabalova, T., Svyatchenko, S., Mostovich, L., Shevchenko, S. & Gulyaeva, L., 1 Dec 2018, In: Surgical Oncology. 27, 4, p. 702-708 7 p.

    Research output: Contribution to journalArticlepeer-review

ID: 3088350